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Pancreatic islet b-cells are particularly susceptible to en-
doplasmic reticulum (ER) stress, which is implicated in
b-cell dysfunction and loss during the pathogenesis of
type 1 diabetes (T1D). The peripheral membrane protein
GAD65 is an autoantigen in human T1D. GAD65 synthe-
sizes g-aminobutyric acid, an important autocrine and
paracrine signaling molecule and a survival factor in islets.
We show that ER stress in primary b-cells perturbs the
palmitoylation cycle controlling GAD65 endomembrane
distribution, resulting in aberrant accumulation of the pal-
mitoylated form in trans-Golgi membranes. The palmitoy-
lated form has heightened immunogenicity, exhibiting
increased uptake by antigen-presenting cells and T-cell
stimulation compared with the nonpalmitoylated form.
Similar accumulation of GAD65 in Golgi membranes is
observed in human b-cells in pancreatic sections from
GAD65 autoantibody-positive individuals who have not yet
progressed to clinical onset of T1D and from patients with
T1Dwith residual b-cell mass and ongoing T-cell infiltration
of islets. We propose that aberrant accumulation of immu-
nogenic GAD65 in Golgi membranes facilitates inappropri-
ate presentation to the immune system after release from
stressed and/or damaged b-cells, triggering autoimmunity.
The g-aminobutyric acid (GABA)–synthesizing enzyme
GAD exists in two isoforms, GAD65 and GAD67, encoded
by different genes (1). The smaller isoform, GAD65, is an
early target of autoimmunity in 70–80% of patients who
develop type 1 diabetes (T1D) (2–4). Rat and human
b-cells primarily express GAD65, but no GAD65 is de-
tected at the protein level in mouse b-cells (5,6). Our
understanding of how GAD65 becomes an autoantigen
in T1D is limited due to the lack of this protein in b-cells
of mice, and therefore, an apparent lack of a significant role
in the pathogenesis of diabetes in the highly studied NOD
mouse model of T1D (7).
The GAD65 enzyme is synthesized in the cytosol as a
hydrophilic cytosolic molecule that undergoes hydro-
phobic posttranslational modifications in the N-terminal
domain to become membrane anchored (8–11). The first
step of hydrophobic modifications is irreversible and re-
sults in a hydrophobic form that targets specifically to the
cytosolic face of endoplasmic reticulum (ER) and cis-Golgi
membranes, establishing an equilibrium between membrane
and cytosolic pools (12). The second step of modifications,
which include stabilization of membrane anchoring, fol-
lowed by a reversible double palmitoylation of cysteines
30 and 45 (10) by a Golgi localized protein acyl transferase
DHHC17 (also known as HIP14) (13), result in trapping of
GAD65 in Golgi membranes, sorting to the trans-Golgi
network (TGN) and targeting to an axonal vesicular path-
way in route to synaptic vesicles in presynaptic clusters in
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neurons and to peripheral vesicles in b-cells (12,14,15).
Palmitoylation is not required for anchoring of GAD65 to
Golgi membranes but is critical for anterograde targeting of
GAD65 from cis-Golgi to TGN membranes and post-Golgi
peripheral vesicles (12). A depalmitoylation step by an acyl
protein thioesterase can release GAD65 from peripheral
vesicle membranes and/or TGN membranes, mediating ret-
rograde trafficking back to Golgi membranes by a nonve-
sicular pathway. The protein can then enter a cycle of
repalmitoylation and depalmitoylation (12). Palmitoylation
is suggested to serve a critical function in regulating the
rate of GABA synthesis in the presynaptic compartment of
neurons (16,17).
Pancreatic b-cells have a well-developed, extensive, and
highly active ER, reflecting their role in synthesizing and
secreting large amounts of insulin. When the protein syn-
thesis and secretion machinery becomes overloaded, due
to a high physiological demand on a limited number of
cells or from exogenous stressors, such as inflammation
or a diet high in fatty acids, the accumulation of unfolded
and improperly folded proteins transiting through the ER
results in the cell experiencing a state of ER stress (18).
b-Cells are highly sensitive to ER stress, which is impli-
cated in the pathogenesis of T1D (19–22). It has been
proposed that the initiation of autoimmunity against
the b-cell follows an initial period of prolonged b-cell
ER stress and apoptosis, induced by inflammatory cyto-
kines secreted by early invading immune cells as well as by
the b-cells themselves (19,23).
Here we report a dramatic effect of ER stress on the
subcellular distribution of the T1D autoantigen GAD65 in
primary rat and human b-cells and accumulation of a
more highly immunogenic palmitoylated form in Golgi
membranes. A similar accumulation is detected in pancre-
atic sections of human GAD65 autoantibody-positive in-
dividuals and patients with T1D.
RESEARCH DESIGN AND METHODS
Cell Cultures
INS-1E rat insulinoma cells (24) were cultured in RPMI
1640 with GlutaMAX, 10% FBS, 1% penicillin/streptomycin
(P/S), 1 mmol/L sodium pyruvate, 10 mmol/L HEPES,
and 50 mmol/L b-mercaptoethanol. The DR4 (DRA1*0101,
DRB1*0401)-positive human Epstein Barr virus–transformed
B-cell line Priess (25) was cultured in Iscove’s Modified
Dulbecco’s Medium GlutaMAX medium with 10% FBS,
and 1% P/S. A DR4 (DRA1*0101, DRB1*0401) restricted
mouse T-cell hybridoma cell line T33.1, recognizing the
GAD65 aa 274-286 epitope (GAD65274-286) (26), was cul-
tured in RPMI 1640 with GlutaMAX, 10% FBS, 1% P/S, and
0.1% b-mercaptoethanol. Primary rat hippocampal neu-
rons were prepared from 2- to 3-day-old Sprague-Dawley
rats, as previously described by Codazzi et al. (27).
Islet Culture
Rat islets isolated from P5 Sprague-Dawley rats as previ-
ously described (15) were cultured in RPMI 1640, 10% FBS,
and 1% P/S at 37°C in 5% CO2. Human islets were cultured
in Connaught Medical Research Laboratories 1066 with
2 mmol/L L-glutamine, 25 mmol/L HEPES, 10% FBS,
and 1% P/S at 25°C in 5% CO2.
Islet Single-Cell Cultures
Rat or human islets dissociated into single cells by digestion
with trypsin-EDTA were cultured at 50,000 cells/well on
laminin-coated Thermanox coverslips (Nunc) or 100,000
cells/well on Fluorodishes (World Precision Instruments) in
minimum essential medium, 11 mmol/L glucose, 5% FBS,
1 mmol/L sodium pyruvate, 10 mmol/L HEPES, 13 B-27
(Gibco), and 1% P/S at 37°C in 5% CO2.
Human Pancreatic Sections
Human pancreatic sections were obtained from the JDRF
Network for Pancreatic Organ Donors with Diabetes
(nPOD) tissue bank (28,29). Sections were obtained from
eight autoantibody-negative healthy donors with normal
islets (Supplementary Table 1), eight individuals who
were potentially prediabetic and positive for GAD65
autoantibodies (GADA+) (Supplementary Table 2), and
eight autoantibody-positive patients with T1D, including
six who were GADA+ (Supplementary Table 3). Donors
were selected to have remaining insulin-positive b-cells
to enable analyses of the subcellular localization of
GAD65. Furthermore, we sought to include individuals
who were reported by nPOD as positive for CD3+ T-cell
infiltration and/or insulitis (Supplementary Tables 2 and
3). Insulitis is defined by nPOD as the presence of six or
more CD3+ T cells immediately adjacent to or within
three or more islets of a defined minimum size in pan-
creatic sections (30).
Immunofluorescence Staining
Human pancreas sections were deparaffinized, followed
by acidic-pH heat–mediated antigen retrieval. Cultures of
single pancreatic islet cells were fixed with 4% parafor-
maldehyde. Samples were blocked and permeabilized in
PBS with 0.3% Triton X-100 and 10% goat or donkey
serum. Primary antibodies CHOP (1:100; sc-575, Santa
Cruz Biotechnology), GAD6 mouse monoclonal antibody
(mAb) against C-terminus of GAD65 (31) (1:1,000); N-GAD65
mouse mAb against the N-terminus of GAD65 (32) (1:300),
giantin (1:1,000; ab24586, Abcam); insulin (1:10,000; 4011-
01, Linco); insulin (1:2,000; ab14042, Abcam), and CD3
(1:30; M7254, Dako) were incubated overnight at 4°C in
PBS with 0.3% Triton X-100 and 1% goat or donkey serum.
Alexa Fluor conjugated secondary antibodies (Molecular
Probes) were incubated at 1:200 dilution in PBS with
0.3% Triton X-100 for 30 min at room temperature.
Image Capture, Analysis, and Quantification
Samples were imaged on a Zeiss LSM700 confocal micro-
scope with 633/1.40 NA Plan-Apochromat oil-immersion
objective for single islet cells and 403/1.30 NA Plan-
Apochromat oil-immersion objective for pancreatic tis-
sue sections. All images for quantification within a single
experiment were captured with the same laser power and
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detector gain. The ratio of GAD65 mean fluorescence inten-
sity (MFI) in the Golgi compartment and post-Golgi vesicles
compared with the rest of the cytosol was calculated with
a custom ImageJ macro. Individual b-cells in a given field
of view were identified and outlined by hand. For each
cell, the macro automatically defined a region of inter-
est (ROI) outlining the Golgi compartment, identified
by giantin costain or by characteristic morphology and
brightness thresholding of GAD65 stain, and GAD65+
vesicles, identified by brightness thresholding of GAD65+
bright puncta. A second ROI defined the remainder of the
cell, excluding the Golgi, GAD65+ vesicles, and nucleus.
GAD65 Golgi accumulation was reported as the ratio of
MFI for the two ROIs.
SDS-PAGE and Western Blotting
Gel electrophoresis was performed with the NuPAGE
system (Invitrogen) with transfer onto polyvinylidene
fluoride membranes with the iBlot 2.0 (Life Technologies)
device. Membranes were blocked with Odyssey Blocking
Buffer (LI-COR Biosciences), incubated in primary anti-
body GAD1701 (a custom antibody against C-terminus of
GAD67 that reacts equally well with GAD65 and GAD67
[5], 1:5,000) overnight at 4°C, and detected with second-
ary antibody IRDye 800CW (LI-COR Biosciences). Blots
were imaged on the LI-COR Odyssey scanner.
Treatment of Cells to Induce ER Stress
Sodium palmitate (1 mmol/L) (Sigma-Aldrich) was conju-
gated to fatty acid–free BSA (0.17 mmol/L) (Calbiochem)
in 150 mmol/L NaCl (pH 7.4) for 1 h. Stock palmitate-
BSA (1 mmol/L palmitate and 0.17 mmol/L BSA) was
added to culture media to achieve a final palmitate con-
centration of 0.1 mmol/L or 0.5 mmol/L. A stock solution
of BSA (0.17 mmol/L BSA) without palmitate was added
to the control (untreated) wells. Thapsigargin (Invitrogen)
was used at a final concentration of 2 mmol/L. Rat
interferon-g and rat interleukin (IL)-1b (R&D Systems)
were used at a final concentration of 10 units/mL for each.
Fluorescence Recovery After Photobleaching Imaging
and Analysis
Fluorescence recovery after photobleaching (FRAP) exper-
iments were performed on a Zeiss LSM700 confocal mi-
croscope with environmental stage at 512 3 512 pixel
resolution, 1% laser power, and 1.94-s frame interval.
GAD65-GFP fluorescence in the Golgi compartment of
transfected cells, treated or not to induce ER stress, was
bleached with 50% laser power. Time-stacks of GAD65-
GFP fluorescence recovery in the Golgi compartment were
double normalized for percentage of initial intensity and
whole-cell photobleaching in ImageJ. Two-phase and
single-phase association curves were plotted in GraphPad
Prism software to obtain half-time of recovery.
S-Acylation Resin-Assisted Capture Palmitoylation Assay
S-Acylation resin-assisted capture (Acyl-RAC) on recombi-
nant human GAD65 (rhGAD65; FIRS Laboratories, RSR)
was performed as described by Forrester et al. (33).
Uptake of GAD65-488 by Priess Cells
rhGAD65 was depalmitoylated overnight by treatment
with 200 mmol/L hydroxylamine (HA) and labeled with
DyLight 488 NHS Ester (Thermo Fisher Scientific). Palmi-
toylated or depalmitoylated GAD65-488 was incubated at
10 mg/mL with 50,000 Priess cells/well in 96-well plates.
Cells were stained with LIVE/DEAD Aqua (Molecular
Probes) and analyzed by Cyan Flow Cytometer (Beckman
Coulter) and FlowJo software.
Activation of GAD65-Specific T Cells
Unmodified rhGAD65 containing native palmitate modi-
fications or HA-treated depalmitoylated GAD65 were in-
cubated overnight with 50,000 Priess cells/well at 2 mg/mL
in 96-well plates. GAD65 loaded Priess cells were then in-
cubated for 24 h with 30,000 T33.1 T cells. IL-2 secretion
was analyzed by ELISA kit (eBioscience).
Plasmids
Generation of GAD65-GFP and GAD65(C30,45A)-GFP
was described previously (11,12,14). INS-1E and primary
rat islet cells were transfected by Lipofectamine 2000
(Invitrogen).
Statistics
Means among three or more groups were compared by
ANOVA in GraphPad Prism 6 software. If deemed signif-
icant, Tukey post hoc pairwise comparisons were per-
formed. Means between two groups were compared using
the Student t test. A 95% CI was considered significant.
Ethical Approval
Animals were used under École Polytechnique Fédérale de
Lausanne (EPFL) animal regulation guidelines and a pro-
tocol approved by the Institutional Animal Care and Use
Committee. Human islets were received from the Univer-
sity Hospital of Geneva and San Raffaele Scientific Insti-
tute, Milan, through the European Consortium for Islet
Transplantation (ECIT) islets for basic research program
and were approved by the University Hospital of Geneva
Institutional Review Board (CER No. 05-028) and by the
San Raffaele Scientific Institute of Milan Ethics Commit-
tee (IPF002-2014). Human pancreatic sections obtained
from the nPOD tissue bank, University of Florida, Gainesville,
FL, were harvested from cadaveric organ donors by certified
organ procurement organizations partnering with nPOD in
accordance with organ donation laws and regulations and
were classified as “nonhuman subjects” by the University of
Florida Institutional Review Board (28,29). EPFL grants
permit for the use of human material as long as the pro-
vider can certify that the samples were obtained according
to local laws and regulations as well as good practices in the
country where they were collected.
RESULTS
ER Stress Results in Accumulation of GAD65
in the Golgi Compartment
Primary rat and human b-cells derived from dissociated
whole islets were cultured as monolayers on coverslips to
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allow for high-resolution confocal microscopy. The mono-
layer islet cells were fixed and immunostained for insulin,
GAD65, and the Golgi marker giantin (Fig. 1). As previ-
ously reported (15), GAD65 is detected diffuse in the
cytosol as well as in Golgi membranes and post-Golgi
vesicles in b-cells. Insulin is detected in distinct large
dense core vesicles.
To induce mild ER stress, primary islet cell monolayers
were subjected to 48 h of low levels (10 units/mL) of the
inflammatory cytokines IL-1b and interferon-g or over-
night treatment with the saturated fatty acid palmitate
(500 mmol/L) (Fig. 2), both of which have been previously
shown to trigger ER stress in b-cells (34–36). Cells were
also treated for 8 h with thapsigargin, which is a potent
ER stress–inducing agent (37) (Fig. 2). We monitored ER
stress by nuclear translocation of CHOP, a multifunc-
tional transcription factor in the ER stress response
(Fig. 2).
The different treatment conditions resulted in varying
degrees of ER stress, as shown by the time frame until
nuclear translocation of CHOP, indicating that the different
treatment conditions affected the cells with variable strength
and specificity. Although incubation with thapsigargin
or palmitate induced CHOP activation at 8 and 18 h,
Figure 1—Confocal analyses of GAD65 localization in primary b-cells. A: Primary rat b-cells immunostained for GAD65 and giantin (Golgi)
show a subcellular distribution of GAD65 in the cytosol and the Golgi compartment. Apart from the Golgi compartment, GAD65 is localized
to vesicles, which are distinct from insulin granules. The confocal images are representative of similar analyses of seven independent
isolations of rat islets. Scale bar: 10 mm. B: Immunostaining of primary human b-cells for GAD65, giantin, and insulin reveals localization of
GAD65 in the Golgi compartment as well as in peripheral vesicles distinct from insulin-containing vesicles. The confocal images are
representative of similar analyses of independent isolations of human islets from four donors. Scale bar: 10 mm.
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respectively, CHOP activation was detected at 48 h
(but not 24 h) of cytokine treatment (Fig. 2). Notably,
all three treatment conditions resulted in a marked
increase in the Golgi-localization of GAD65 (Fig. 2).
Accumulation of GAD65 in Golgi membranes during
palmitate-induced ER stress was also observed in pri-
mary human b-cells and in another cell type expressing
GAD65, primary rat hippocampal GABA-ergic neurons
(Supplementary Fig. 1).
Accumulation of GAD65 in the Golgi compartment
during induction of ER stress by palmitate or thapsigargin
was confirmed by costaining for the Golgi marker giantin
(Fig. 3A and Supplementary Fig. 1A–C), but Golgi struc-
tures are also clearly identifiable by GAD65 localization in
b-cells and neurons (12,15,38). Quantification after a 2-h
incubation with palmitate or thapsigargin revealed a sig-
nificant accumulation of GAD65 in the Golgi compart-
ment (Fig. 3B and Supplementary Fig. 1D).
The time course of accumulation of GAD65 in Golgi
membranes during palmitate-induced ER stress was stud-
ied further. Rat islet cell monolayers were treated with
100 or 500 mmol/L palmitate for 10 min, 2 h, and 18 h
and immunostained for CHOP, GAD65, and insulin (Fig.
4 and Supplementary Fig. 2). Golgi accumulation of
GAD65 occurred almost immediately upon addition of
palmitate and was clearly visible at 10 min (Fig. 4A
and Supplementary Fig. 2A). The strong Golgi accumu-
lation of GAD65 persisted at 2 h and was still visible at
18 h, although the intensity began to fade coinciding with
activation of CHOP (Fig. 4C and D). Quantification of
GAD65 membrane accumulation showed a statistically sig-
nificant increase in the ratio of MFI for GAD65 in the Golgi
compartment for cells incubated for 10 min and 2 h in
100 or 500 mmol/L palmitate (Fig. 4B). Across all condi-
tions and times, there were no notable changes in the sub-
cellular localization of insulin (Supplementary Fig. 2B).
Taken together, the results indicate that induction of ER
stress results in aberrant accumulation of GAD65 in the
Golgi compartment.
Palmitoylation Is Required for GAD65 Accumulation
in the Golgi Compartment During ER Stress
The distribution of GAD65 between ER/cis-Golgi and TGN/
vesicular membranes is controlled by its palmitoylation–
depalmitoylation–repalmitoylation cycle. Although palmi-
toylation of cysteines 30 and 45 is not required for firm
anchoring of GAD65 to Golgi membranes, it is critical
for its anterograde trafficking from cis-Golgi to TGN
membranes and targeting to post-Golgi vesicles (12). We
assessed whether a palmitoylation-deficient mutant of
GAD65 was capable of accumulating in the Golgi compart-
ment in b-cells undergoing ER stress. Primary rat b-cells
were transfected with wild-type (WT) GAD65-GFP or pal-
mitoylation-deficient GAD65(C30,45A)-GFP, and treated
with palmitate or thapsigargin for 1 h to induce ER stress.
Cells were imaged live by confocal microscopy, and the
images were measured for MFI of GAD65-GFP in the Golgi
compartment (Fig. 5). ER stress induced by palmitate or
thapsigargin significantly increased the fraction of WT
GAD65-GFP in Golgi and vesicle membranes, but palmitoy-
lation-deficient GAD65(C30,45)-GFP was unaffected (Fig. 5).
Figure 2—Activation of ER stress pathways in b-cells by thapsigargin, palmitate, or inflammatory cytokines. Primary rat b-cells were
treated with palmitate (500 mmol/L, 18 h), thapsigargin (2 mmol/L, 8 h), or cytokines (10 units/mL, 8, 24, or 48 h) to induce ER stress and
immunostained for GAD65 (top two panels) and CHOP (bottom panel). GAD65-positive Golgi compartments are indicated by arrowheads.
For all three treatment modules, GAD65 expression in the Golgi compartment becomes noticeably brighter. The middle panels show
increased magnification of framed regions in the top panels. The confocal images are representative of similar analyses of six independent
isolations of rat islets. Scale bars: 10 mm.
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Thus, Golgi accumulation of GAD65 in response to ER stress
is restricted to palmitoylation-competent GAD65.
Recovery of WT but Not Palmitoylation-Deficient
GAD65 in the Golgi Compartment After
Photobleaching Is Inhibited During ER Stress
We next assessed the effect of ER stress on the kinetics
of replenishment of WT GAD65-GFP as well as the
palmitoylation-deficient mutant GAD65(C30,45A)-GFP into
Golgi membranes after irreversible photobleaching. We
previously reported that the FRAP of WT GAD65-GFP in
Golgi membranes involves two pools of the protein, a
rapid pool and a slow pool (12). The rapid Golgi replen-
ishment pool represents the nonpalmitoylated form of
GAD65, which has undergone the first step of hydropho-
bic modifications resulting in weak on/off membrane
association. The second and slower replenishment pool
represents palmitoylation-competent GAD65, which, af-
ter anterograde vesicular trafficking to the TGN and pe-
riphery, can undergo depalmitoylation and nonvesicular
retrograde trafficking back to Golgi membranes. INS-1E
cells (Fig. 6A–D) and primary rat islet cells (Supplementary
Figs. 3 and 4) were subjected to irreversible photobleach-
ing of the Golgi compartment. Recovery of GAD65-GFP
in Golgi membranes was recorded for untreated cells and
for cells pretreated with palmitate (Fig. 6 and Supple-
mentary Fig. 3) or thapsigargin (Supplementary Fig. 4)
Figure 3—Treatment of b-cells with palmitate or thapsigargin promotes Golgi accumulation of GAD65. A: Primary rat b-cells were treated
with palmitate (500 mmol/L, 2 h) or thapsigargin (2 mmol/L, 2 h) to induce ER stress and immunostained for GAD65 and giantin. Scale bars:
10 mm. B: Image quantification of GAD65 accumulation in the Golgi compartment reported as the ratio of MFI for GAD65 in the Golgi
compartment and GAD65-positive vesicles to MFI for GAD65 in the rest of the cell, excluding the nucleus. Results are presented as mean6
SEM (n = 39–43 b-cells from eight image fields analyzed per condition). Cells positive for giantin and negative for GAD65 represent non–b-
islet cells. Data were analyzed using one-way ANOVA, followed by the Tukey multiple comparisons test. ***P < 0.001. Analyses of
accumulation of GAD65 in Golgi membranes in rat b-cells, human b-cells, and rat hippocampal neurons incubated with palmitate for
2 h are shown in Supplementary Fig. 1.
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for 1 h to induce early-stage ER stress. Analysis of the
data were performed using nonlinear regression, assum-
ing one or multiple pools of replenishing protein. In-
duction of ER stress significantly impaired the Golgi
replenishment kinetics of WT GAD65-GFP in INS-1E cells
treated with palmitate (Fig. 6C and D) and in primary islet
cells treated with palmitate (Supplementary Fig. 3) or
thapsigargin (Supplementary Fig. 4). In contrast, the
Golgi replenishment kinetics of palmitoylation-deficient
GAD65(C30,45A)-GFP was similar for untreated and
treated cells (Fig. 6C and D and Supplementary Figs.
3 and 4). Calculations of half-time of recovery of the rapid
Figure 4—Time course of Golgi accumulation of GAD65 upon palmitate treatment. A: Confocal analyses of monolayer cultures of primary
rat b-cells treated or not with 100 mmol/L or 500 mmol/L palmitate for 10 min, 2 h, and 18 h, respectively. Fixed cells were immunostained
for GAD65 and CHOP. Scale bar: 10 mm. B: Image quantification of GAD65 accumulation in the Golgi compartment reported as the ratio of
MFI for GAD65 in the Golgi and GAD65-positive vesicles to MFI for GAD65 in the rest of the cell, excluding the nucleus. Results are
presented as mean 6 SEM (n = 28–45 cells from 4–5 image fields analyzed per condition). Data were analyzed using two-way ANOVA,
followed by the Tukey multiple comparisons test. *P < 0.05, **P < 0.01, and ***P < 0.001. C: Image quantification of CHOP-positive nuclei
as a percentage of total nuclei. Results are presented as mean 6 SEM (n = 4–10 image fields analyzed per condition). Data were analyzed
using two-way ANOVA, followed by the Tukey multiple comparisons test. **P < 0.01 and ***P < 0.001; ns, not significant. Corresponding
lower magnification images of primary rat b-cells stained for GAD65 and insulin are shown in Supplementary Fig. 2. hr, hour.
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and slow pools of WT GAD65-GFP revealed that although
the half-time of recovery of the rapid pool replenishing
the Golgi was minimally or not affected, the half-time of
recovery of the slow pool was increased three- to fourfold
(Fig. 6C and D and Supplementary Figs. 3 and 4). The
results of these experiments indicate that ER stress,
whether induced by palmitate or thapsigargin, inhibits
and perturbs the palmitoylation cycle of WT GAD65-GFP.
Uptake and Processing of GAD65 by Antigen-
Presenting B Lymphocytes Is Enhanced by
Palmitoylation
Given that modification of peptides and proteins by
palmitoylation may enhance their immunogenicity (39),
we assessed whether the palmitoylation state of GAD65
has an effect on its uptake by antigen-presenting cells
(APCs) and/or activation of T cells in an APC/T-cell coculture
assay. rhGAD65 produced in yeast was depalmitoylated by
thiol-acyl cleavage with HA, and depalmitoylation was con-
firmed biochemically by the Acyl-RAC assay (33) (Fig. 7A).
Analyses of uptake of DyLight-488–labeled palmitoylated
and nonpalmitoylated GAD65 by the HLA-DR4 (DRB1*0401)–
positive human B-cell line Priess revealed a 2.5-fold in-
crease in uptake of palmitoylated GAD65 compared with
the depalmitoylated GAD65 (Fig. 7B). Furthermore, Priess
cells were loaded with palmitoylated or depalmitoylated
GAD65 and used as APCs to stimulate the GAD65-specific
HLA-DR4 (DRB1*0401)–restricted murine T-cell hybrid-
oma line T33.1 that recognizes the GAD65274-286 epitope.
In this APC/T-cell coculture assay, presentation of pal-
mitoylated GAD65 induced a threefold higher secretion
of IL-2 by T33.1 cells compared with the depalmitoylated
protein (Fig. 7C). Taken together, the results indicate
that palmitoylation facilitates uptake and processing
of GAD65 by APCs, resulting in increased antigen-
specific stimulation of T cells. Thus the palmitoylated
form of GAD65 that accumulates in Golgi during ER
stress has higher immunogenicity, consistent with a
possible role of ER stress in activating autoreactive T
cells in T1D.
Figure 5—Palmitoylation is required for Golgi accumulation of GAD65. A: Primary rat b-cells were transfected with WT GAD65-GFP or the
palmitoylation-deficient mutant GAD65(C30,45A)-GFP and imaged live after a 1-h treatment with palmitate (500 mmol/L) or thapsigargin
(2 mmol/L) to induce ER stress. Images are also displayed with a heatmap to highlight the increase in Golgi and vesicle brightness. Golgi
regions are indicated with a dashed outline. Scale bar: 10 mm. B: Image quantification of GAD65 accumulation in the Golgi compartment
expressed as the ratio of MFI for GAD65 in the Golgi and GAD65-positive vesicles to MFI for GAD65 in the rest of the cell, excluding the
nucleus. Results are presented as mean 6 SEM (n = 6–10 cells analyzed per condition). Data were analyzed using one-way ANOVA,
followed by the Tukey multiple comparisons test. *P < 0.05; ns, not significant.
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Figure 6—FRAP in the Golgi of WT but not palmitoylation-deficient GAD65 is inhibited during ER stress. A: Live cell images of INS-1E cells
transfected with GAD65-GFP before and after treatment with palmitate (500 mmol/L) for 1 h show accumulation of GAD65-GFP in the Golgi.
Scale bar: 10 mm. B: Representative images from FRAP analyses of INS-1E cells expressing WT GAD65-GFP or palmitoylation-deficient
GAD65(C30,45A)-GFP. The entire Golgi compartment was photobleached, and recovery of fluorescence was followed by live cell imaging.
Scale bar: 10 mm.C: Kinetics of fluorescence recovery after bleaching the entire Golgi-associated pool of WTGAD65-GFP or GAD65(C30,45A) in
INS-1E cells pretreated or not with palmitate for 1 h. Results from a representative experiment are presented as mean 6 SEM (n = 10 cells per
condition). D: Calculated halftimes of Golgi fluorescence recovery in INS-1E cells after photobleaching. WT GAD65-GFP exhibits two-phase
recovery kinetics corresponding to a rapid as well as a slow recovery pool, while palmitoylation-deficient GAD65(C30,45A)-GFP exhibits single-
phase recovery kinetics corresponding to a rapid recovery pool. Results are presented as the mean halftime of recovery 6 SEM (n = 3 in-
dependent experiments, 10 cells per experiment). Data were analyzed by Student t test comparing the halftime parameter between the
association curve fits of the combined data set from three independent experiments. ***P < 0.001; ns, not significant. FRAP analyses of
GAD65 Golgi recovery in primary rat b-cells treated with palmitate or thapsigargin are shown in Supplementary Fig. 3 and Supplementary
Fig. 4, respectively. hr, hour; sec, second.
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GAD65 Accumulates in the Golgi Compartment
in Human b-Cells During Progression of T1D
Autoimmunity
We addressed the question of whether the experimental
accumulation of GAD65 in the Golgi compartment induced
by treatment with ER stressors in vitro is of relevance for
human diabetes. Human pancreatic sections provided by
the nPOD tissue bank (28,29) representing eight healthy
donors (Supplementary Table 1), eight individuals with
potential prediabetes and GADA+ (Supplementary Table 2),
and eight patients with T1D with residual b-cell mass (Sup-
plementary Table 3) were immunostained for GAD65,
giantin, insulin, glucagon, and the pan–T-cell marker CD3
(Fig. 8A–D). In five of eight GADA+ individuals and seven
of eight patients with T1D, the GAD65 signal in b-cell
Golgi membranes compared with cytosol was higher than
one SD above the mean for healthy control individuals
where GAD65 immunostaining was mostly uniform (Fig.
8E and Supplementary Tables 1–3, last column). Staining
of serial sections for the pan–T-cell marker, CD3 (Fig. 8A),
confirmed peri- and intraislet infiltrating T cells in islets
from three of eight GADA+ individuals and in six of eight
patients with T1D (Fig. 8A and results not shown). Exam-
ination of the patient information (Supplementary Tables
1–3) for individual donors provided by nPOD revealed that
the highest Golgi accumulation observed in the GADA+
group with prediabetes was from a single autoantibody-
positive (GADA+) 2.2-year-old child expressing the HLA-class
II T1D susceptibility haplotype DR4, DQ8 (Supplementary
Table 2) showing infiltrates of CD3+ T cells in and around
islets (Fig. 8A, nPOD 6090) but not meeting the nPOD
insulitis criteria (Supplementary Table 2). This child may
represent a case of a young, genetically susceptible indi-
vidual in the early stages of autoimmunity associated
with development of T1D. The lowest Golgi accumula-
tion in the GADA+ group was observed in a 31-year-old,
single-autoantibody–positive (GADA+) individual with
normal islet morphology and no insulitis (Supplemen-
tary Table 2, nPOD 6181). The highest Golgi accumula-
tion observed in the group with T1D was observed in a
double-autoantibody–positive (GADA+ and microinsulin
autoantibody assay+) 11-year-old individual expressing
the T1D HLA-class II susceptibility haplotypes DR3,
DQ2 and DR4, DQ8 and with ongoing insulitis (Sup-
plementary Table 3) (30) as confirmed by our CD3
immunostaining (Fig. 8A, nPOD 6265). Taken together,
the results suggest that aberrant accumulation of GAD65
in Golgi membranes may correlate with active islet auto-
immunity in human T1D.
DISCUSSION
Accumulation of GAD65 in Golgi Membranes in b-Cells
Experiencing ER Stress and/or Active Autoimmunity
In this study, we show that treatment of islet cell cultures
by three separate regimens known to induce ER stress in
b-cells results in accumulation of GAD65 in Golgi mem-
branes. Importantly, analysis of human pancreatic tissue
sections revealed significant accumulation of GAD65 in
b-cell Golgi membranes in GADA+ individuals with po-
tential prediabetes and in patients with T1D with resid-
ual b-cell mass. Thus, aberrant accumulation of GAD65
in Golgi membranes is observed in b-cells in culture
Figure 7—Palmitoylation confers increased immunogenicity upon GAD65. A: Recombinant human GAD65 produced in yeast was shown to
be palmitoylated by the Acyl-RAC assay. Free thiols in recombinant GAD65 were capped with methyl methanethiosulfonate, followed by
cleavage of palmitate-thiol modifications with HA, pulldown with a thiol-reactive pyridyl-disulfide agarose resin, and detection by Western
blot. Lanes: i, input, positive control of unmodified recombinant GAD65; –HA, negative control without HA, resulting in no palmitate
cleavage and no protein pulldown; +HA, HA added with palmitate groups cleaved and protein recovered by thiol-reactive pulldown. B:
Time course of uptake of equimolar amounts of DyLight-488–labeled palmitoylated or depalmitoylated (HA cleaved) recombinant GAD65 by
MHC-class II DR4–positive human Priess B-cell APCs measured by flow cytometry. Results are presented as mean 6 SEM (n = 3 exper-
imental replicates). Data were analyzed by two-way ANOVA, followed by the Tukey multiple comparisons test. ***P < 0.001. C: Priess cells
were loaded with equimolar amounts of palmitoylated or depalmitoylated GAD65 (HA cleaved) and tested for stimulation of the DR4
restricted GAD65-specific T33.1 T-cell hybridoma cells by IL-2 secretion measured by ELISA. Peptide, GAD65274-286 epitope. Results
are presented as mean 6 SEM (n = 3 experimental replicates). Data were analyzed by two-way ANOVA, followed by the Tukey multiple
comparisons test. ***P < 0.001; ns, not significant.
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undergoing experimentally induced ER stress as well as in
b-cells of individuals experiencing active b-cell autoimmunity.
GAD65 in Pancreatic b-Cells Undergoes a
Palmitoylation–Depalmitoylation–Repalmitoylation
Cycle That Is Perturbed During ER Stress Resulting in
Accumulation of the Protein in Golgi Membranes
We have shown earlier that palmitoylation of GAD65
results in anterograde trafficking from cis-Golgi to TGN
membranes (12). The evidence presented in this study
shows that only WT GAD65, but not palmitoylation-
deficient GAD65(C30,45A), accumulates in Golgi mem-
branes during ER stress. This increase of GAD65 in Golgi
membranes is consistent with the accumulated protein
representing the palmitoylated form of GAD65 in TGN
membranes, suggesting that the palmitoylation cycle of
GAD65 significantly slows down during induction of ER
stress. This retardation in transport likely affects the
control of GAD65 distribution between peripheral vesi-
cle membranes, where most of the GAD65 enzymatic
functional activity is believed to take place, and Golgi
membranes, which may serve as a sorting station for
this protein. We therefore propose that perturbation in
the regulation of GAD65 membrane distribution by ER
stress may have negative consequences for GABA synthesis
Figure 8—Confocal analyses of islets in paraffin sections of human pancreas from healthy donors, donors who were GAD65 autoantibody-
positive but without diabetes, or donors with T1D with residual b-cell mass. A: Immunostaining of human pancreatic sections for insulin,
glucagon, or CD3 from the indicated nPOD case numbers. The arrowheads indicate CD3+ T cells. Scale bar: 50 mm. B: The same human
islet from a serial section, immunostained for GAD65 and giantin. Scale bar: 50 mm. C: Increased magnification of GAD65 staining in the
framed region shown in B. Scale bar: 10 mm. D: Thresholded binary images of the same region in C show the colocalization (Coloc.) between
giantin (Golgi) and the bright GAD65 signal. Scale bar: 10 mm. E: Image quantification of GAD65 accumulation in the Golgi compartment in
three representative islets from eight individuals per donor category, reported as the ratio of MFI for GAD65 in the Golgi of b-cells to MFI for
GAD65 in the rest of the cell, excluding the nucleus. Results are presented as scatter dot plots overlaying the mean 6 SEM (n = 24 islets
from eight donors). Data were analyzed by one-way ANOVA, followed by the Tukey multiple comparisons test. *P < 0.05, **P < 0.01. The
average GAD65 Golgi accumulation calculated per individual and demographic information for healthy, GADA+, and donors with T1D are
listed in Supplementary Tables 1–3.
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and secretion. GABA serves as an important signaling mol-
ecule and survival/growth factor in islets of Langerhans
(40).
The mechanisms by which cytokines, palmitate, and
thapsigargin induce ER stress in b-cells may differ (34).
One commonality between the three different treatments
is that each is implicated in dysregulation of Ca2+ homeo-
stasis (41). Inflammatory cytokines and thapsigargin have
both been shown to induce b-cell ER stress through
downregulation or inhibition of the sarcoplasmic/ER Ca2+
ATPase, resulting in elevation of cytosolic Ca2+ concentra-
tions and depletion of ER Ca2+ stores (42). Palmitate is
reported to induce ER stress through lipotoxic signaling
pathways mediating a block in ER uptake of Ca2+ and a
sustained depletion of ER Ca2+ stores (35,43). The idea
that dysregulation of ER/cytosolic Ca2+ concentrations is
involved in Golgi accumulation of GAD65 is supported by
the fact that a similar effect could be achieved by strongly
depolarizing cells by abruptly elevating extracellular glu-
cose or KCl concentration (E.A.P., C.C., and S.B., unpub-
lished results). Although how a change in Ca2+ homeostasis
could affect membrane trafficking of GAD65 is currently
unknown, it is of note that earlier studies have suggested
modulation of the affinity of GAD65 to liposome mem-
branes by Ca2+ ion concentration (44). Interestingly, there
is evidence to suggest that palmitate treatment of insuli-
noma cells alters the lipid composition of endomem-
branes and specifically disrupts lipid raft microdomains
(45), a dynamic hub for palmitoylated proteins (46). It is
of note that distribution of H-Ras into lipid rafts is
regulated by its palmitoylation–depalmitoylation cycle
(47), which shares similarities with the acylation cycle
of GAD65 (16). Thus, it is possible that alterations in lipid
raft composition are part of the mechanism involved in
perturbation of GAD65 trafficking and accumulation in
Golgi membranes.
Accumulation of Palmitoylated GAD65 in Golgi
Membranes May Have Implications for Initiation of
Autoimmunity
Parallel to the important role of GAD65 as the highly
regulated and the only GABA-synthesizing enzyme in
human b-cells, it can assume a detrimental role as a
major target of autoimmunity associated with pancreatic
human b-cell destruction and development of T1D in
genetically susceptible individuals (2). The autoantige-
nicity of GAD65 is in stark contrast to the highly homol-
ogous GAD67 isoform, which is not an independent
autoantigen. GAD67 primarily differs from GAD65 in
the N-terminal domain (48) that mediates hydrophobic
posttranslational modifications, membrane anchoring,
palmitoylation, and trafficking of GAD65 (12), suggest-
ing that this region is integral to the susceptibility of
GAD65 to become a pathogenic autoantigen. GAD67
does not undergo hydrophobic modifications (49) and
can only be targeted to membranes by piggybacking
onto other proteins (15,38).
Our data show that compared with depalmitoylated
GAD65, palmitoylated GAD65 induces a significantly
stronger effector T-cell response by the T-cell hybrid-
oma T33.1, which recognizes GAD65274-286 in the context
of DR4, a T1D MHC-class II susceptibility haplotype.
Palmitoylation of peptide epitopes has been shown to
enhance immunogenicity of autoimmune epitopes in ex-
perimental autoimmune encephalomyelitis (50) and in
synthetic peptide vaccines (51). Palmitoylation of a pro-
tein increases its avidity for binding to membranes. The
uptake of palmitoylated GAD65 by the DR4-positive hu-
man B-cell line Priess was significantly enhanced com-
pared with nonpalmitoylated GAD65. We posit that the
increase in uptake, conferred by palmitoylation, may in-
volve enhanced binding to the surface of Priess cells
resulting in increased uptake by endocytosis and en-
hanced targeting to late endosomes for proteolytic pro-
cessing and presentation to T cells in the context of
MHC-class II antigens (reviewed by Blum et al. [52]).
Palmitoylation of GAD65 may also affect antigen unfold-
ing and proteolysis and alter the hierarchy of peptides
displayed to CD4+ T cells. The T33.1 hybridoma reporter
cell line is clonally restricted to a single MHC-class II
binding epitope, GAD65274-286, which is distant from
the palmitoylated cysteine residues in GAD65, aa 30 and
45. Therefore, the possibility of palmitoylation increasing
the MHC-class II binding affinity of this epitope can be
excluded in our experimental system.
Rather, we suggest that increased stimulation of T33.1
cells reflects a quantitative increase in the levels of the
GAD65274-286 epitope available for binding to DR4 in late
endosomes and elevated expression on the surface of Pri-
ess cells. If palmitoylated GAD65, which has accumulated
in TGN during ER stress, is released by distressed or dying
b-cells and encountered by APCs, its heightened immu-
nogenicity compared with nonpalmitoylated GAD65 may
stimulate autoimmunity in genetically predisposed indi-
viduals. An important agenda for future studies will be to
elucidate the mechanisms by which palmitoylated, immu-
nogenic GAD65 is released from b-cells undergoing ER
stress, as well as the determinants of that stress, which
the results presented here suggest could be key factors in
the mechanism that results in autoimmunity to GAD65
associated with development of T1D.
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